3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
12
Phase 2
9
Phase 1/2
8
Phase EARLY_PHASE1
2
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
314
Carcinoma, Non-Small-Cell Lung
161
Breast Neoplasms
125
Neoplasm Metastasis
105
Melanoma
94
Leukemia, Myeloid, Acute
80
Lymphoma
79
Multiple Myeloma
74
Colorectal Neoplasms
73
Ovarian Neoplasms
69
Lymphoma, Non-Hodgkin
63
Recurrence
58
Prostatic Neoplasms
55
Pancreatic Neoplasms
51
Lung Neoplasms
49
Glioblastoma
39
Carcinoma, Renal Cell
39
Precursor Cell Lymphoblastic Leukemia-Lymphoma
38
Lymphoma, Large B-Cell, Diffuse
37
Leukemia, Lymphocytic, Chronic, B-Cell
37
Leukemia
36
Advanced Solid Tumors
36
Myelodysplastic Syndromes
35
Triple Negative Breast Neoplasms
33
Head and Neck Neoplasms
33
Sarcoma
31
Brain Neoplasms
31
Urinary Bladder Neoplasms
30
Stomach Neoplasms
30
Lymphoma, Follicular
28
Interventions
Mitomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Has results
×
Non-Muscle Invasive Bladder Neoplasms
×
Clear all
NCT02316171
2022-07-27
CANON
Viralytics
Phase 1
Completed
16 enrolled
8 charts